{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-009894","form_type":"8-K","ticker":"PAVM","cik":"0001624326","company_name":"PAVmed Inc.","filed_at":"2024-03-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.848792+00:00","generated_at":"2026-06-04T19:37:59.075909+00:00","sec_items":["1.01","3.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"PAVmed extends senior secured note maturities to 2025; pays $2M for covenant waiver","bullets":["April 2022 Note maturity extended to April 4, 2025; September 2022 Note to September 8, 2025.","Holder waived financial covenant (30% market cap to principal ratio) from Dec 1 2023 to Aug 31 2024.","PAVmed to pay $2M cash (or agreed form) by April 25, 2024 for the amendment and waiver.","Covenant waiver conditioned on company market capitalization not falling below $75M during period."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-009894","json":"https://secwatch.observer/filing/0001493152-24-009894.json","markdown":"https://secwatch.observer/filing/0001493152-24-009894.md","text":"https://secwatch.observer/filing/0001493152-24-009894.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1624326/000149315224009894/0001493152-24-009894-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1624326/000149315224009894/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T19:37:59.075909+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f47b7c4386f5b718b9b967e587d785f39e82d044","claim":"PAVmed Inc. amended Amendment and Waiver with holder of senior secured convertible notes valued at $2,000,000 cash payment; maturity extended to April 4, 2025 (April 2022 Note) and September 8, 2025 (effective 2024-03-12).","evidence_excerpt":"Effective as of March 12, 2024, PAVmed Inc. (the “ Company ”), entered into an amendment and waiver (the “ Amendment and Waiver ”) with the holder of the senior secured convertible note issued by the Company as of April 4, 2022 (the “ April 2022 Note ”) and the secured convertible note issued by the Company as of September 8, 2022 (the “ September 2022 Note ,” and together with the April 2022 Note, the “ Notes ”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1624326/000149315224009894/0001493152-24-009894-index.htm","confidence":0.95,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"credit facility"},{"label":"Counterparty","value":"holder of senior secured convertible notes"},{"label":"Value","value":"$2,000,000 cash payment; maturity extended to April 4, 2025 (April 2022 Note) and September 8, 2025"},{"label":"Effective","value":"2024-03-12"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}